TETRAGRAPH | EMG BASED QUANTITATIVE NEUROMUSCULAR MONITOR

A world without anesthesia- and respiratory-related complications

Read more

Investors

Senzime targets a market opportunity valued more than SEK 40 billion per year.

NEWS

TetraSens Pediatric

Every child deserves a safe anesthesia procedure. The launch of our latest product, TetraSens Pediatric is an important milestone to provide a safe procedure with state-of-the-art neuromuscular blockade management also for the pediatric population.

TetraSens Pediatric is a sensor array that is designed for the sensitive skin of a child and engineered to deliver the most accurate results, to provide ease of mind and confidence during any surgical procedure in any surgical position.

TetraSens Pediatric has FDA 510k-clearance and is CE marked.

A Swedish medical device company

Senzime develops, manufactures and markets CE- and FDA-cleared patient monitoring systems.

Our vision is a world without anesthesia- and respiratory-related complications.

CEO Statement

Accelerating sales growth in the US and Europe, strategic partnership with global leader and acquisition in the US

Pia Renaudin
CEO

Press Releases

Explore our patient monitoring solutions

Get product details

How can Senzime’s products help to eliminate in-hospital complications?
Contact us to discuss your needs or schedule a product demo.